166 related articles for article (PubMed ID: 10410437)
21. Steroid or calcineurin inhibitor-sparing immunosuppressive protocols.
Grinyó JM; Cruzado JM
Contrib Nephrol; 2005; 146():30-42. PubMed ID: 15567918
[TBL] [Abstract][Full Text] [Related]
22. Exploiting tolerance processes in transplantation.
Waldmann H; Cobbold S
Science; 2004 Jul; 305(5681):209-12. PubMed ID: 15247471
[TBL] [Abstract][Full Text] [Related]
23. Patterns of allosensitization in allograft recipients: long-term cardiac allograft acceptance is associated with active alloantibody production in conjunction with active inhibition of alloreactive delayed-type hypersensitivity.
VanBuskirk AM; Wakely ME; Sirak JH; Orosz CG
Transplantation; 1998 Apr; 65(8):1115-23. PubMed ID: 9583874
[TBL] [Abstract][Full Text] [Related]
24. The Effect of Immunosuppressive Drugs on MDSCs in Transplantation.
Yang F; Li Y; Zhang Q; Tan L; Peng L; Zhao Y
J Immunol Res; 2018; 2018():5414808. PubMed ID: 30057917
[TBL] [Abstract][Full Text] [Related]
25. Regulatory T cells: first steps of clinical application in solid organ transplantation.
van der Net JB; Bushell A; Wood KJ; Harden PN
Transpl Int; 2016 Jan; 29(1):3-11. PubMed ID: 25981203
[TBL] [Abstract][Full Text] [Related]
26. Immunobiology of cardiac allograft and xenograft transplantation.
Pietra BA; Gill RG
Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu; 2001; 4():123-57. PubMed ID: 11460981
[TBL] [Abstract][Full Text] [Related]
27. Effective use of donor MHC class I gene therapy in organ transplantation: prevention of antibody-mediated hyperacute heart allograft rejection in highly sensitized rat recipients.
Geissler EK; Graeb C; Tange S; Guba M; Jauch KW; Scherer MN
Hum Gene Ther; 2000 Feb; 11(3):459-69. PubMed ID: 10697120
[TBL] [Abstract][Full Text] [Related]
28. Amplification of natural regulatory immune mechanisms for transplantation tolerance.
Chen ZK; Cobbold SP; Waldmann H; Metcalfe S
Transplantation; 1996 Nov; 62(9):1200-6. PubMed ID: 8932256
[TBL] [Abstract][Full Text] [Related]
29. Transplantation tolerance. A complex scenario awaiting clinical applicability.
Sayegh MH; Perico N; Remuzzi G
Contrib Nephrol; 2005; 146():95-104. PubMed ID: 15567924
[TBL] [Abstract][Full Text] [Related]
30. Alloimmunity and Tolerance in Corneal Transplantation.
Amouzegar A; Chauhan SK; Dana R
J Immunol; 2016 May; 196(10):3983-91. PubMed ID: 27183635
[TBL] [Abstract][Full Text] [Related]
31. The immunological monitoring of alloreactive responses in liver transplant recipients: a review.
Reding R; Gras J; Truong DQ; Wieërs G; Latinne D
Liver Transpl; 2006 Mar; 12(3):373-83. PubMed ID: 16498661
[TBL] [Abstract][Full Text] [Related]
32. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
[TBL] [Abstract][Full Text] [Related]
33. Modifying graft immunogenicity and immune response prior to transplantation: potential clinical applications of donor and graft treatment.
Martins PN; Chandraker A; Tullius SG
Transpl Int; 2006 May; 19(5):351-9. PubMed ID: 16623870
[TBL] [Abstract][Full Text] [Related]
34. Intrathymic immunomodulation and the "infectious" tolerance pathway in allograft recipients.
Reemtsen BL; Kato H; Wang TS; Busuttil RW; Kupiec-Weglinski JW; Goss JA
J Surg Res; 1999 Jun; 84(1):1-7. PubMed ID: 10334880
[TBL] [Abstract][Full Text] [Related]
35. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.
Pan H; Zhao K; Wang L; Zheng Y; Zhang G; Mai H; Han Y; Yang L; Guo S
J Surg Res; 2010 May; 160(2):315-24. PubMed ID: 19524257
[TBL] [Abstract][Full Text] [Related]
36. Apoptosis, graft rejection, and transplantation tolerance.
Kabelitz D
Transplantation; 1998 Apr; 65(7):869-75. PubMed ID: 9565088
[TBL] [Abstract][Full Text] [Related]
37. De novo production of antibodies after heart or lung transplantation should be regarded as an early warning system.
Rose ML
J Heart Lung Transplant; 2004 Apr; 23(4):385-95. PubMed ID: 15063397
[No Abstract] [Full Text] [Related]
38. Immunology insights into cardiac allograft rejection.
Savasta M; Lentini S
Rev Cardiovasc Med; 2011; 12(2):e68-76. PubMed ID: 21796085
[TBL] [Abstract][Full Text] [Related]
39. Tolerance in heart transplantation: the Holy Grail, or an attainable goal?
Pierson RN
Heart Fail Clin; 2007 Jan; 3(1):17-29. PubMed ID: 17545006
[TBL] [Abstract][Full Text] [Related]
40. [Graft rejection reaction and immunosuppression following heart transplantation].
Leonardi L; Lüthy A; Mondada C; Waser M; Laske A; Turina M; Gallino A
Ther Umsch; 1990 Feb; 47(2):147-51. PubMed ID: 2180104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
